NCT07360886 Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
| NCT ID | NCT07360886 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Olomouc |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-11-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop accessible methods for the early detection of selected neuropathologies in drivers, focusing on multiple sclerosis and Parkinson's disease. The primary objective is to identify clinical tests that correlate with outcomes from the Vienna Test System (VTS), thereby enabling early diagnosis without the need for complex neurological or neuropsychological assessments. Findings could improve the effectiveness of routine driver medical check-ups and inform future modifications to Czech traffic law to enhance road safety.
Eligibility Criteria
Inclusion Criteria: * Person after signing informed consent. * After meeting the valid diagnostic criteria for the given neurological diagnosis. * Possession of a valid driver's license and proof of active driving. * Age limit 18 - 85 years. Exclusion Criteria: * Proven diagnosis of dementia based on a current psychological examination (MMSE 24 points or less). * Diagnosis of a disease or condition that, according to Czech Law. No. 277/2004 Coll., on medical fitness to drive motor vehicles, as amended (especially Law No. 204/2025 Coll.), prevents or significantly limits the ability to drive a motor vehicle safely (e.g. dementia, epilepsy, severe disorders of consciousness). * Age less than 18 years. * Age more than 85 years. * In the second cohort (patients with Multiple Sclerosis), proven and treated relapse in the last 6 weeks before inclusion in the study. * In the MS cohort, current EDSS \> 6.5 points. * For the PD cohort, the current Hoehn and Yahr scale score is greater than or equal to 4. * For both cohorts, evidence of parainfectious deterioration as demonstrated by laboratory testing.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07360886 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07360886 currently recruiting?
Yes, NCT07360886 is actively recruiting participants. Contact the research team at Dalibor.Zimek@fnol.cz for enrollment information.
Where is the NCT07360886 trial being conducted?
This trial is being conducted at Olomouc, Czechia.
Who is sponsoring the NCT07360886 clinical trial?
NCT07360886 is sponsored by University Hospital Olomouc. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.